At a glance
- Originator Novo Nordisk
- Class Antiepileptic drugs; Anxiolytics; Neuroprotectants; Oxadiazoles; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Anxiety disorders; Epilepsy
Most Recent Events
- 09 Nov 1995 Discontinued-Preclinical for Anxiety disorders in Denmark (Unknown route)
- 09 Nov 1995 Discontinued-Preclinical for Epilepsy in Denmark (Unknown route)
- 06 Oct 1994 Preclinical development for Anxiety disorders in Denmark (Unknown route)